Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability.

BACKGROUND Recent investigations showed some correlation between three-dimensional (3D) treatment planning dose-volume data (dose-volume histograms: DVH, dose statistics) and rectal toxicity for patients treated for prostate cancer. However, no data are available about the possible impact of inter-institute variability in contouring the rectum, so that the possibility of reliably using information from single-centre studies remains doubtful. PURPOSE Within a retrospective three-institutes study on correlation between dose-volume treatment planning data and rectum bleeding in patients treated for prostate cancer, an investigation about the impact of inter- and intra-observer variability in contouring the rectum was performed. MATERIALS AND METHODS Ten patients were considered for a dummy run exercise and three observers (one per Institute) contoured the rectum (including filling). An anatomically based definition of rectum extension was previously accepted by the three observers. Six of the ten patients were randomly chosen in the subgroup of patients (large spacing, LS) with a distance between computed tomography (CT) slices (outside the prostate region) equal to 10 mm; for the remaining four patients the distance between CT slices was 5 mm over the whole rectum volume (small spacing, SS). The original 3D treatment planning was recovered on the Cadplan treatment planning system for each patient and rectum dose statistics (mean, median and maximum rectum dose), volume, DVH and NTCP values were calculated for each observer. For DVH analysis, the values of V(50), V(55), V(60), V(65) and V(70) (defined as the % of rectum volume receiving at least 50, 55, 60, 65, 70 Gy) were considered. Normal tissue complication probabilities (NTCPs) were calculated for the original ICRU dose and for a 75.6 Gy ICRU dose (NTCP and NTCP(75.6), respectively). Intra-observer variability was investigated by asking the observers to redraw the same rectum contours 6 months later and comparing the two contouring sessions. RESULTS In general, a good agreement was found for most patients and, in particular, for all SS patients. The impact of inter-observer variability was quite significant on dose statistics and DVH in two of six LS patients. Looking at the patient population, some systematic deviations, even if quite small, were demonstrated between institute B and institute C (volume, P = 0.02) and between institute A and institute B (mean/median dose, V(50)-V(65), NTCP(75.6); P < 0.05). Four of six LS patients (0/4 in the SS group) presented a maximum difference among observers at the cranial and/or caudal limit of the rectum equal to 1 cm. For these patients, inter-observer variability was significantly higher than for the others (P < 0.03). When inter-observer variability was expressed in terms of standard deviations (SD), values around 2-3 Gy and 0.5 Gy for LS and SS patients, respectively, were found for mean/median dose; values around 3-4% and 0.5-2% for LS and SS patients, respectively, were found for V(50)-V(70). The average SD for NTCP and NTCP(75.6) were 0.4 and 0.6%, respectively (0.5 and 0.9% for LS patients; 0.2 and 0.3% for SS patients). Intra-observer variability was found to be lower than inter-observer variability even if the impact on dose statistics and DVH was visible. CONCLUSIONS Once a robust definition of rectum is assessed, inter- and intra-institute variability in contouring the rectum appear relatively modest. However, the results suggest that the number of LS patients in DVH correlation studies should be as low as possible; the low number of these patients in the multi-centric trial involving our institutions should not have significant impact on the results of the study.

[1]  L. Gras,et al.  Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. , 1998, International journal of radiation oncology, biology, physics.

[2]  C. Fiorino,et al.  Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  D. Dearnaley,et al.  Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  R K Ten Haken,et al.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.

[5]  A Pollack,et al.  Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. , 2000, International journal of radiation oncology, biology, physics.

[6]  R Mohan,et al.  A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. , 1996, International journal of radiation oncology, biology, physics.

[7]  G. Storme,et al.  Routine clinical use of on-line portal imaging (OPI) using siemens beamview , 1991 .

[8]  C. Ling,et al.  1008 Correlation of DVH and treatment planning variables with late rectal bleeding after 3D-CRT of prostate cancer: What is the best way to define the rectal length and volume? , 1999 .

[9]  D P Dearnaley,et al.  Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. , 2001, International journal of radiation oncology, biology, physics.

[10]  Mageras,et al.  Control, Correction, and Modeling of Setup Errors and Organ Motion. , 1995, Seminars in radiation oncology.

[11]  R Calandrino,et al.  Variations of tumor control and rectum complication probabilities due to random set-up errors during conformal radiation therapy of prostate cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  M S Hoogeman,et al.  Dose-wall histograms and normalized dose-surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[13]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[14]  P. Maguire,et al.  Clinical and dosimetric predictors of radiation-induced esophageal toxicity. , 1999, International journal of radiation oncology, biology, physics.

[15]  M M Urie,et al.  Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. , 1996, International journal of radiation oncology, biology, physics.

[16]  S. Fosså,et al.  Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[17]  C. Ling,et al.  Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. , 2000, International journal of radiation oncology, biology, physics.

[18]  W. van Putten,et al.  Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. , 1990, International journal of radiation oncology, biology, physics.

[19]  T E Schultheiss,et al.  Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. , 1996, International journal of radiation oncology, biology, physics.

[20]  A Ottolenghi,et al.  Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model. , 1996, The British journal of radiology.

[21]  G J Kutcher,et al.  Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. , 2001, International journal of radiation oncology, biology, physics.

[22]  M van Herk,et al.  Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[23]  I. Lax,et al.  Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  M. Goitein,et al.  Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.

[25]  Icru Prescribing, recording, and reporting photon beam therapy , 1993 .

[26]  J. Fenwick Impact of dose-distribution uncertainties on rectal ntcp modeling. II: Uncertainty implications. , 2001, Medical physics.

[27]  C J Moore,et al.  Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. , 1997, The British journal of radiology.

[28]  D. Spelbring,et al.  A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapy. , 1995, International journal of radiation oncology, biology, physics.

[29]  C. Ling,et al.  Rectal bleeding after conformal radiotherapy of prostate cancer and dose volume histograms , 1998 .

[30]  B Sanchez-Nieto,et al.  BIOPLAN: software for the biological evaluation of. Radiotherapy treatment plans. , 2000, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[31]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[32]  M van Herk,et al.  Comparison of prostate cancer treatment in two institutions: a quality control study. , 1999, International journal of radiation oncology, biology, physics.

[33]  G J Kutcher,et al.  Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. , 1995, International journal of radiation oncology, biology, physics.